Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 277 participants.

Also called NCT02628899

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 277 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02628899
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02628899. Non-randomized; no masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2023-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
Condition
Aortic Stenosis
Intervention (Device)
Transfemoral TAVR (transcatheter aortic valve replacement)
Intervention (Device)
SAVR
Lead sponsor
Medstar Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct02628899
Content hash
3fe26d3018fd7f6f296406c830f2ffd93b52ea5184a29d6d521a1ff286d6ab85